What is Relay Therapeutics Inc?
operates as a clinical-stage precision medicines company.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 4.00B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 219,517 shares $257k | 0 |
| 9-12months | 793,302 shares $724k | 0 |